Two cases of chronic hepatitis B with emergence of lamivudine-resistant virus during long-term therapy

Hepatology Research

Volumn 13, Issue 2, 1999, Pages 97-104

  Fujioka, Shin Ichi ^a   Shimomura, Hiroyuki ^a   Fujio, Kozo ^a   Ikeda, Fusao ^a   Miyake, Masanobu ^a   Ishii, Yasushi ^a   Itoh, Mamoru ^a   Sakaguchi, Kosaku ^a   Tsuji, Takao ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Antiviral therapy; Hepatitis B virus; Hronic hepatitis; Lamivudine; Mutation

Indexed keywords

LAMIVUDINE;

ADULT; AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DRUG EFFECT; DRUG POTENCY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOCOMPETENCE; LONG TERM CARE; MALE; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0032938009     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(98)00078-3     Document Type: Article

References (17)

1. Hoofnagle JH, Lau D. New therapies for chronic hepatitis B. J Viral Hepat 1997; 4: 41-50.
2. Dienstag J.L., Perrilo R.P., Schiff E.R., Bartholomew M., Vicary C., Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. New Engl J Med 1995; 333: 1657-1661.
3. Lai CL, Ching CK, Tung AK, et al. Lamivudine is effective in suppressing hepatitis B virus in DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology 1997; 25: 241-244.
4. Benhamou Y, Dohin E, Lunel-Fabiani F, et al. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet 1995; 345: 396-397.
5. Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24: 711-713.
6. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistence to lamivudine in vivo. Hepatology 1996; 24: 714-717.
7. Bain VG, Kneteman NM, Ma MM, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456-1462.
8. Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212-1215.
9. Tisdale M, Kemp SD, Parry NR, Larder BA. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc Natl Acad Sci USA 1993; 90: 5653-5656.
10. Schuurman R, Nijhuis M, van Leeuwen R, et al. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistent virus populations in persons treated with lamivudine (3TC). J Infect Dis 1995; 171: 1411-1419.
11. Ichida F, Tsuji T, Omata M, et al. new Inuyama classification: new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996; 6: 112-119.
12. Kaneko S, Feinstone SM, Miller RH. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol 1989; 27: 1930-1933.
13. Bartholomew MM, Jansen RW, Jeffers LJ, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349: 20-22.
14. Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir adminstration are replication defective. Hepatology 1998; 27: 638-633.
15. Maoumov NV, Perrillo RP, Chokski A, et al. Reduction in hepatitis B virus quasispecies during lamuvidine treatment is associated with enhanced virus replication and hepatocytolysis. Hepatology 1995; 22: 328A.
16. Honkoop P, Niesters HG, de Man RA, Osterhaus AD, Schalm SW. Lamivudine resistence in immunocompetent chronic hepatitis B. Incidence and patterns. J Hepatol 1997; 26: 1393-1395.
17. Honkoop P, de Man RA, Heijtink RA, Schalm SW. Hepatitis B reactivation after lamivudine. Lancet 1995; 346: 1156-1157.